nitrendipine has been researched along with Albuminuria in 21 studies
Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.
Albuminuria: The presence of albumin in the urine, an indicator of KIDNEY DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study was designed to evaluate the effects of an ACE inhibitor, lisinopril, and a calcium antagonist, nitrendipine, on urinary albumin excretion (UAE) and renal function in mild to moderate essential hypertensive patients with microalbuminuria." | 9.09 | Effects of lisinopril and nitrendipine on urinary albumin excretion and renal function in patients with mild to moderate essential hypertension. ( Haneda, T; Hasebe, N; Hayakawa, T; Hirayama, T; Ide, H; Kato, J; Kikuchi, K; Maruyama, J; Morimoto, H; Obara, A; Ogawa, Y; Tanaka, H, 2000) |
| "A trial to study the efficacy, safety and tolerability of nitrendipine and enalapril in the treatment of diabetic hypertensive patients with microalbuminuria (MA) was performed to compare the effects of both drugs in the prevention of the renal impairment." | 9.08 | Nitrendipine and enalapril in the treatment of diabetic hypertensive patients with microalbuminuria. ( Cases, A; Closas, J; Cobos, A; Esmatges, E; Pascual, R; Piñol, C; Planas, J; Soler, J, 1996) |
| "The effect of short- (98 days) and long-term (1 year) treatment with nitrendipine (10 to 40 mg/d) and enalapril (5 to 20 mg/d) on kidney function was studied prospectively in a parallel group design in 16 microalbuminuric non-insulin-dependent diabetic patients with mild hypertension and biopsy-proven diabetic glomerulopathy." | 9.07 | Long-term treatment with either enalapril or nitrendipine stabilizes albuminuria and increases glomerular filtration rate in non-insulin-dependent diabetic patients. ( Bianchi, L; Campana, M; Cortesi, L; Mecca, G; Mosconi, L; Pagani, G; Remuzzi, G; Ruggenenti, P, 1994) |
| "The effect of a 6-week treatment with the calcium channel blocker nitrendipine or the angiotensin converting enzyme inhibitor enalapril on blood pressure, albuminuria, renal hemodynamics, and morphology of the nonclipped kidney was studied in rats with two-kidney, one clip renovascular hypertension." | 7.68 | Adverse effect of the calcium channel blocker nitrendipine on nephrosclerosis in rats with renovascular hypertension. ( Helmchen, U; Schoeppe, W; Schwietzer, G; Troschau, G; Wenzel, UO, 1992) |
| "In normotensive patients with incipient diabetic nephropathy low-dose administration of enalapril, nitrendipine and placebo does not result in clear cut differences in albuminuria." | 6.68 | Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy. ( Bender, R; Berger, M; Heinemann, L; Janicke, I; Sawicki, PT, 1996) |
| "In 11 hypertensive patients with chronic renal failure we studied the short-term effects of the calcium antagonist nitrendipine, the angiotensin-converting enzyme inhibitor cilazapril, and the combination of both drugs on blood pressure, renal hemodynamics, and proteinuria in a randomized, double-blind, placebo-controlled way." | 6.67 | Effects of nitrendipine and cilazapril on renal hemodynamics and albuminuria in hypertensive patients with chronic renal failure. ( Huysmans, FT; Kleinbloesem, CH; Kloke, HJ; Koene, RA; van Hamersvelt, HW; Wetzels, JF, 1990) |
| "The present study was designed to evaluate the effects of an ACE inhibitor, lisinopril, and a calcium antagonist, nitrendipine, on urinary albumin excretion (UAE) and renal function in mild to moderate essential hypertensive patients with microalbuminuria." | 5.09 | Effects of lisinopril and nitrendipine on urinary albumin excretion and renal function in patients with mild to moderate essential hypertension. ( Haneda, T; Hasebe, N; Hayakawa, T; Hirayama, T; Ide, H; Kato, J; Kikuchi, K; Maruyama, J; Morimoto, H; Obara, A; Ogawa, Y; Tanaka, H, 2000) |
| "After a 4-week washout period, mildly hypertensive (systolic blood pressure [sBP] > or = 140 mmHg and/or diastolic blood pressure [dBP] > or = 90 mmHg) NIDDM patients with albuminuria (15-200 micrograms/min) were randomized into an 8-month-long therapy with either nitrendipine (n = 11) or enalapril (n = 10)." | 5.08 | Effects of enalapril and nitrendipine on the excretion of epidermal growth factor and albumin in hypertensive NIDDM patients. ( Hwang, DL; Josefsberg, Z; Lev-Ran, A; Ross, SA, 1995) |
| "A trial to study the efficacy, safety and tolerability of nitrendipine and enalapril in the treatment of diabetic hypertensive patients with microalbuminuria (MA) was performed to compare the effects of both drugs in the prevention of the renal impairment." | 5.08 | Nitrendipine and enalapril in the treatment of diabetic hypertensive patients with microalbuminuria. ( Cases, A; Closas, J; Cobos, A; Esmatges, E; Pascual, R; Piñol, C; Planas, J; Soler, J, 1996) |
| "The effect of short- (98 days) and long-term (1 year) treatment with nitrendipine (10 to 40 mg/d) and enalapril (5 to 20 mg/d) on kidney function was studied prospectively in a parallel group design in 16 microalbuminuric non-insulin-dependent diabetic patients with mild hypertension and biopsy-proven diabetic glomerulopathy." | 5.07 | Long-term treatment with either enalapril or nitrendipine stabilizes albuminuria and increases glomerular filtration rate in non-insulin-dependent diabetic patients. ( Bianchi, L; Campana, M; Cortesi, L; Mecca, G; Mosconi, L; Pagani, G; Remuzzi, G; Ruggenenti, P, 1994) |
| "We prospectively measured UAE prior to and 4 and 8 weeks after treatment with enalapril, nitrendipine, atenolol, or a diuretic in 48 patients with essential hypertension and microalbuminuria." | 5.07 | Microalbuminuria in patients with essential hypertension: effects of several antihypertensive drugs. ( Baldari, G; Bianchi, S; Bigazzi, R; Campese, VM, 1992) |
| "This study investigates the efficacy of late intervention with the calcium channel blockers (CCBs) nitrendipine and nisoldipine in preventing development of albuminuria and glomerular hypertrophy in experimental diabetes." | 3.70 | Effect of nitrendipine and nisoldipine on renal structure and function in long-term experimental diabetes in rats. ( Flyvbjerg, A; Grønbaek, H; Nielsen, B; Osterby, R, 2000) |
| "We have recently shown that treatment with the calcium channel blocker nitrendipine may aggravate albuminuria and glomerular injury in rats with two-kidney, one clip renovascular hypertension if arterial blood pressure is not reduced." | 3.69 | Combination treatment of enalapril with nitrendipine in rats with renovascular hypertension. ( Helmchen, U; Schoeppe, W; Schwietzer, G; Wenzel, UO, 1994) |
| " We have investigated whether long-term monotherapy with a calcium antagonist, nitrendipine, prevents the development of overt diabetic nephropathy in type I and type II diabetic patients with mild to moderate hypertension and persistent microalbuminuria (ie, incipient nephropathy)." | 3.68 | Nephroprotective effects of nitrendipine in hypertensive type I and type II diabetic patients. ( Bollen, CC; Bretzel, RG; Federlin, KF; Maeser, E, 1993) |
| "The effect of a 6-week treatment with the calcium channel blocker nitrendipine or the angiotensin converting enzyme inhibitor enalapril on blood pressure, albuminuria, renal hemodynamics, and morphology of the nonclipped kidney was studied in rats with two-kidney, one clip renovascular hypertension." | 3.68 | Adverse effect of the calcium channel blocker nitrendipine on nephrosclerosis in rats with renovascular hypertension. ( Helmchen, U; Schoeppe, W; Schwietzer, G; Troschau, G; Wenzel, UO, 1992) |
| "Pretreatment with nitrendipine did not reduce enzyme excretion, although AAP levels were lower in general in the group assigned to the 20-mg dose." | 2.68 | Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic radiocontrast administration. ( Artero, M; Carraro, M; Cova, M; Faccini, L; Grotto, M; Mancini, W; Stacul, F, 1996) |
| "In normotensive patients with incipient diabetic nephropathy low-dose administration of enalapril, nitrendipine and placebo does not result in clear cut differences in albuminuria." | 2.68 | Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy. ( Bender, R; Berger, M; Heinemann, L; Janicke, I; Sawicki, PT, 1996) |
| "In 11 hypertensive patients with chronic renal failure we studied the short-term effects of the calcium antagonist nitrendipine, the angiotensin-converting enzyme inhibitor cilazapril, and the combination of both drugs on blood pressure, renal hemodynamics, and proteinuria in a randomized, double-blind, placebo-controlled way." | 2.67 | Effects of nitrendipine and cilazapril on renal hemodynamics and albuminuria in hypertensive patients with chronic renal failure. ( Huysmans, FT; Kleinbloesem, CH; Kloke, HJ; Koene, RA; van Hamersvelt, HW; Wetzels, JF, 1990) |
| "Arterial hypertension is the most common chronic medical condition requiring office visits to physicians and is a major contributing factor to the development of myocardial infarction and stroke." | 2.40 | How should we treat hypertensive women with cardiac and renal impairment? ( Ruilope, LM; Suarez, C, 1997) |
| "Nitrendipine treatment was unable to prevent increased GBM in diabetic SHR." | 1.30 | Effect of the calcium channel blocker nitrendipine in normotensive and spontaneously hypertensive, diabetic rats on kidney morphology and urinary albumin excretion. ( Flyvbjerg, A; Grønbaek, H; Nielsen, B; Osterby, R, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 19 (90.48) | 18.2507 |
| 2000's | 2 (9.52) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jungmann, E | 1 |
| Malanyn, M | 1 |
| Mortasawi, N | 1 |
| Unterstöger, E | 1 |
| Haak, T | 1 |
| Palitzsch, KD | 1 |
| Scherberich, J | 1 |
| Schumm-Draeger, PM | 1 |
| Usadel, KH | 1 |
| Fogari, R | 2 |
| Zoppi, A | 2 |
| Pasotti, C | 1 |
| Mugellini, A | 2 |
| Lusardi, P | 2 |
| Lazzari, P | 2 |
| Corradi, L | 2 |
| Ruggenenti, P | 2 |
| Mosconi, L | 2 |
| Bianchi, L | 1 |
| Cortesi, L | 1 |
| Campana, M | 1 |
| Pagani, G | 1 |
| Mecca, G | 2 |
| Remuzzi, G | 2 |
| Wenzel, UO | 2 |
| Helmchen, U | 2 |
| Schoeppe, W | 2 |
| Schwietzer, G | 2 |
| Bretzel, RG | 1 |
| Bollen, CC | 1 |
| Maeser, E | 1 |
| Federlin, KF | 1 |
| Chan, JC | 1 |
| Cockram, CS | 1 |
| Nicholls, MG | 1 |
| Josefsberg, Z | 1 |
| Ross, SA | 1 |
| Lev-Ran, A | 1 |
| Hwang, DL | 1 |
| Carraro, M | 1 |
| Mancini, W | 1 |
| Artero, M | 1 |
| Stacul, F | 1 |
| Grotto, M | 1 |
| Cova, M | 1 |
| Faccini, L | 1 |
| Piñol, C | 1 |
| Cobos, A | 1 |
| Cases, A | 1 |
| Esmatges, E | 1 |
| Soler, J | 1 |
| Closas, J | 1 |
| Pascual, R | 1 |
| Planas, J | 1 |
| Perna, A | 1 |
| Heinemann, L | 1 |
| Janicke, I | 1 |
| Bender, R | 1 |
| Berger, M | 1 |
| Sawicki, PT | 1 |
| Kribben, A | 1 |
| Anlauf, M | 1 |
| Distler, A | 1 |
| Gärtner, H | 1 |
| Holzgreve, H | 1 |
| Michaelis, J | 1 |
| Röcker, L | 1 |
| Schäfers, R | 1 |
| Philipp, U | 1 |
| Wellek, S | 1 |
| Philipp, T | 1 |
| Ruilope, LM | 1 |
| Suarez, C | 1 |
| Preti, P | 1 |
| Nielsen, B | 2 |
| Grønbaek, H | 2 |
| Osterby, R | 2 |
| Flyvbjerg, A | 2 |
| Ogawa, Y | 1 |
| Haneda, T | 1 |
| Hirayama, T | 1 |
| Ide, H | 1 |
| Obara, A | 1 |
| Maruyama, J | 1 |
| Morimoto, H | 1 |
| Tanaka, H | 1 |
| Kato, J | 1 |
| Hayakawa, T | 1 |
| Hasebe, N | 1 |
| Kikuchi, K | 1 |
| Bianchi, S | 2 |
| Bigazzi, R | 2 |
| Baldari, G | 2 |
| Campese, VM | 2 |
| Troschau, G | 1 |
| Kloke, HJ | 1 |
| Wetzels, JF | 1 |
| van Hamersvelt, HW | 1 |
| Koene, RA | 1 |
| Kleinbloesem, CH | 1 |
| Huysmans, FT | 1 |
1 review available for nitrendipine and Albuminuria
| Article | Year |
|---|---|
How should we treat hypertensive women with cardiac and renal impairment?
Topics: Adrenergic beta-Antagonists; Aged; Albuminuria; Antihypertensive Agents; Blood Pressure; Diuretics; | 1997 |
14 trials available for nitrendipine and Albuminuria
| Article | Year |
|---|---|
Effect of 1-year treatment with nitrendipine versus enalapril on urinary albumin and alpha 1-microglobulin excretion in microalbuminuric patients with type 1 diabetes mellitus. A randomized, single-blind comparative study.
Topics: Adult; Albuminuria; Alpha-Globulins; Blood Pressure; Creatinine; Diabetes Mellitus, Type 1; Diabetic | 1994 |
Comparative effects of ramipril and nitrendipine on albuminuria in hypertensive patients with non-insulin-dependent diabetes mellitus and impaired renal function.
Topics: Aged; Albuminuria; Analysis of Variance; Confidence Intervals; Creatinine; Diabetes Mellitus, Type 2 | 1995 |
Long-term treatment with either enalapril or nitrendipine stabilizes albuminuria and increases glomerular filtration rate in non-insulin-dependent diabetic patients.
Topics: Adult; Albuminuria; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Enalapri | 1994 |
Effects of enalapril and nitrendipine on the excretion of epidermal growth factor and albumin in hypertensive NIDDM patients.
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomark | 1995 |
Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic radiocontrast administration.
Topics: Acetylglucosaminidase; Acute Kidney Injury; Aged; Albuminuria; Alpha-Globulins; Angiography, Digital | 1996 |
Nitrendipine and enalapril in the treatment of diabetic hypertensive patients with microalbuminuria.
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; C | 1996 |
Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetes.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Calcium Channel Blocker | 1996 |
Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy.
Topics: Adolescent; Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calc | 1996 |
Hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment. Influence on LVH, proteinuria and metabolic parameters. The HANE Trial Research Group.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Ant | 1997 |
Long-term effects of ramipril and nitrendipine on albuminuria in hypertensive patients with type II diabetes and impaired renal function.
Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Creatinine; D | 1999 |
Effects of lisinopril and nitrendipine on urinary albumin excretion and renal function in patients with mild to moderate essential hypertension.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Fem | 2000 |
Microalbuminuria in patients with essential hypertension: effects of several antihypertensive drugs.
Topics: Adult; Aged; Albuminuria; Analysis of Variance; Antihypertensive Agents; Atenolol; Creatinine; Diure | 1992 |
Effects of nitrendipine and cilazapril on renal hemodynamics and albuminuria in hypertensive patients with chronic renal failure.
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cilazapril; Doub | 1990 |
Microalbuminuria in patients with essential hypertension. Effects of an angiotensin converting enzyme inhibitor and of a calcium channel blocker.
Topics: Adult; Aged; Albuminuria; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Nitrendipine | 1991 |
6 other studies available for nitrendipine and Albuminuria
| Article | Year |
|---|---|
Combination treatment of enalapril with nitrendipine in rats with renovascular hypertension.
Topics: Albuminuria; Animals; Blood Pressure; Diuresis; Drug Therapy, Combination; Enalapril; Glomerular Fil | 1994 |
Nephroprotective effects of nitrendipine in hypertensive type I and type II diabetic patients.
Topics: Albuminuria; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic N | 1993 |
Comparison of ramipril and nitrendipine.
Topics: Albuminuria; Antihypertensive Agents; Diabetes Mellitus, Type 2; Humans; Hypertension; Nitrendipine; | 1995 |
Effect of the calcium channel blocker nitrendipine in normotensive and spontaneously hypertensive, diabetic rats on kidney morphology and urinary albumin excretion.
Topics: Albuminuria; Animals; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Hypertension; Kidne | 1999 |
Effect of nitrendipine and nisoldipine on renal structure and function in long-term experimental diabetes in rats.
Topics: Albuminuria; Animals; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Ex | 2000 |
Adverse effect of the calcium channel blocker nitrendipine on nephrosclerosis in rats with renovascular hypertension.
Topics: Albuminuria; Animals; Antihypertensive Agents; Blood Pressure; Drug Combinations; Enalapril; Hemodyn | 1992 |